Best Uterine Fibroid Treatment Doctors & Fibroid Center In Waukomis,Oklahoma
Dr.Rosalie Elder, MD|
8063 Lakeshore Court
Phone: (802) 609-6996
Business Hours: 8:00 am - 5:00 pm
By Appointment Only: no
Accepts Insurance: Yes
Practice Areas: Family Practice,gynecological care,gynecological care
Dr.Elvera Mccann, MD
882 Rock Maple Street
Business Hours: 10:00 am - 5:00 pm
By Appointment Only: yes
Accepts Insurance: no
Practice Areas: Internal Medicine,obstetrical care,Family Practice
Dr.Kaleigh Hardin, MD|
Waukomis Fertility Care
814 Wellington Drive
Phone: (525) 877-0604
Business Hours: 7:00 am - 5:00 pm
By Appointment Only: No
Accepts Insurance: Yes
Practice Areas: obstetrical care,Fertility,Family Practice
Dr.Vella Groves, MD
Waukomis Family Practice
416 Bohemia Drive
Phone: (669) 650-6343
Business Hours: 11:00 am - 5:00 pm
By Appointment Only: No
Accepts Insurance: no
Practice Areas: Fertility,Family Practice,obstetrical care
Local Resources For Uterine Fibroid Treatment
Endometriosis Uterine Fibroids and Estrogen Dominance- Waukomis, Oklahoma
Now, when we have a stage called quot;estrogen dominancequot;estrogen proliferates tissue when it's dominant. Estrogen within itself is very good. I helps us with our brain tissue, our memory. It helps us to think clearly, prevents quot;foggy brainquot; and all this other stuff. Estrogen in itself is very goodit's not bad. But when you have an estrogen dominance situation where the estrogen is very dominant over the progesterone,.
You're going to have all these symptoms and you're going to have a proliferation of tissue. For instance, if a woman comes in with cysts on her ovaries or cysts in her breasts or she has fibroids on the inner uterine lining, or she has endometriosis these are all tissues that are being proliferated. They are increasing because she's got too much estrogen in her. Thus, we have a lot of.
Increase in the amounts of hysterectomies because women are getting large fibroids and they're bleeding heavy, heavy, heavy, so they have anemia. I went through this myself, personally, in my forties. I had a lot of estrogen dominance but back then we didn't know exactly what to do. And so, I ended up having a hysterectomy because every time my period came I would bleed very heavily. And this is what's happening now in people in their forties. Not everybody, but people with estrogen dominance,.
And so they eventually have to have a hysterectomy. That path can be made smoother. We are starting to get more and more women that are bringing their daughters now. It's so good to seeit's preventive medicine.
Reshaping Interventional Radiology Webinar Magellan Robotics
Brian: Here's our agenda. We have three presenters today. Katzen will provide an introduction to intravascular robotics and discuss its current and future role in interventional procedures. Then, Sterling will provide insights from starting off an intravascular robotics program at Inova Alexandria in Virginia. And finally, Bagla will review the current state of prostatic artery embolization and share how robotics may play a role in the development of this emerging and very promising procedure. Then, we'll have the QA period at the end with all of our presenters. Our first presenter is Barry Katzen. Katzen is the founder and medical director.
Of Miami Cardio and Vascular Institute in Miami, FL. Katzen has been a leader in the development of interventional radiology, and multidisciplinary models for delivering cardiovascular care. He was awarded the gold medal for lifetime achievement by the Society of Interventional Radiology, and was the first American to receive the gold medal from the Cardiovascular and Interventional Radiological Society of Europe, or C.I.R.S.E. Throughout his career, Katzen has been a leader in the development of new, less invasive procedures for the treatment of vascular disease. He and his colleagues at MCVI have been pioneers in the al use of intravascular robotics. Katzen is currently a lead investigator.
On the Rover Registry, which is a postmarket, multi center study of al procedures performed globally with the Magellan Robotic System. Thanks for joining us today, Katzen, and I will now turn it over to you. Katzen: Thank you very much, Brian, and good afternoon, everyone. It's a pleasure for me to participate in this panel and share some of our experience and thoughts about intravascular robotics. If we can go to the next slide, please. Just by way of disclosure, I think you've had a chance to look at that or. Sorry, thank you. Next, please. So we became interested in vascular robotics looking at the increasing importance of robotics.
In health care in general, and looked at the potential of robotics as being able to reduce radiation exposure to patients, operators, and staff, perhaps providing improved precision and reducing the degree of vascular trauma associated with manual catheterization. It's a possible solution for those of us involved in medical education in training physicians of multiple disciplines who have less foundational training experience, and also has the potential to facilitate more complex procedures for operators who are missing this foundation. As we go to the next slide, we begin to see some of the components of the Magellan Robotic System. On your left is the robotic arm that stays on the patient's table side, and to.
Your right is the actual remote physician console. These can be coordinated both remotely on the table side. In this animation, you can see at first the robotic remote animation, and this is the robotic arm on the table involving the components that allow us to steer the device. We have the ability to controle the guidewire in multiple directions, including advancement and rotation, as you see here, as the wire is held within this driving system that exists on the robotic arm. All of this can be controlled by this remote station. One of the other advantages of robotic catheterization is our ability to actually manipulate the catheter in three dimensions. We begin to think this way as we start to use robotics.
In terms of trying to drive through the center of the vessel versus tracking against the wall of the vessel as we advance the catheter and the devices. In the next slide, you'll see some of the movements that exist in the 6 French device. You can see here that that involves two points of motion: a curvilinear change at the distal end. And you can see how we're actually changing the shape into a reverse head hunter, a long multipurpose catheter, or something resembling a right coronory as we have multiple controls in these two bending sites. The concept with this 6 French is different than with the 9 French coaxial system becuase of these multiple bend points and the ability to actually obtain.
The distal sweep in 360 degrees, as you see in this table top demonstration. Here you can see the three principal catheters that exist right now from a commercial point of view: the fundamental 9 French catheter, which involves a 6 French intraluminal sheath, and a 6 French sheath and a leader catheter, the 6 French device in the middle, which is the one you just saw the animation of, and then the next generation product which we should see soon, which also involves the movable sheath, and the distal leader catheter. This will allow, essentially, the introduction of any type of therapeutic device that will fit through a 7 French sheath. The 9 French allows the equivalent of any 6 French IV delivery.